(Q37969891)

26 August 2017

Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy (English)

1 reference

26 August 2017

1 reference

Rajesh Kharbanda

2

0 references

Adrian Banning

object named as

Adrian P Banning

series ordinal

3

0 references

author name string

Stephen Westaby

series ordinal

1

1 reference

PubMed ID

22182955

26 August 2017

language of work or name

English

0 references

publication date

20 December 2011

1 reference

Nature Reviews Cardiology

26 August 2017

1 reference

26 August 2017

9

1 reference

26 August 2017

158-171

1 reference

26 August 2017

3

1 reference

Cardiogenic shock complicating acute coronary syndromes

26 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Ten-year trends in the incidence and treatment of cardiogenic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

21 January 2018

12 December 2020

Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

No-reflow phenomenon and prognosis in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Mechanism of myocardial "stunning".

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Cardiogenic shock: current concepts and improving outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Ventricular septal rupture after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Postinfarction ventricular septal defects: towards a new treatment algorithm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Trends in incidence and mortality rates of ventricular septal rupture during acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Ventricular septal rupture complicating acute myocardial infarction: clinical characteristics and contemporary outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Post-infarction cardiac rupture: surgical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Subacute ventricular free wall rupture complicating myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Pathophysiology of cardiogenic shock complicating acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Perioperative outcome and long-term survival of surgery for acute post-infarction mitral regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary Events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries f

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Predictors of outcome after percutaneous treatment for cardiogenic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Measurement of cardiac reserve in cardiogenic shock: implications for prognosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Management of cardiogenic shock complicating acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Comparison of Dopamine and Norepinephrine in the Treatment of Shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Medical and surgical treatment of acute right ventricular failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Right ventricular function and positive pressure ventilation in clinical practice: from hemodynamic subsets to respirator settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Clinical indication for use and outcomes after inhaled nitric oxide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Withdrawal of statins increases event rates in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Outcome after cardiac arrest in adults in UK hospitals: effect of the 1997 guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality. Part 1: Indications and evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

European Resuscitation Council guidelines for resuscitation 2005. Section 4. Adult advanced life support

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Application of therapeutic hypothermia in the intensive care unit. Opportunities and pitfalls of a promising treatment modality--Part 2: Practical aspects and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Current Spectrum of Cardiogenic Shock and Effect of Early Revascularization on Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Relationship between progressive microvascular damage and intramyocardial hemorrhage in patients with reperfused anterior myocardial infarction: myocardial contrast echocardiographic study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Cardiogenic shock in ACS. Part 2: Role of mechanical circulatory support

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

The potential impact of primary percutaneous coronary intervention on ventricular septal rupture complicating acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Acquired ventricular septal defect during acute myocardial infarction: Analysis of 38 unoperated necropsy patients and comparison with 50 unoperated necropsy patients without rupture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Frequency of collateral blood flow in the infarct-related coronary artery in rupture of the ventricular septum after acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Effect of thrombolytic therapy on the risk of cardiac rupture and mortality in older patients with first acute myocardial infarction†

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Reliability of electromechanical dissociation in the diagnosis of left ventricular free wall rupture in acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Results of surgery for irreversible moderate to severe mitral valve regurgitation secondary to myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Early risk stratification of patients with cardiogenic shock complicating acute myocardial infarction who undergo percutaneous coronary intervention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Cardiac pumping capability and prognosis in heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Inhalation of the phosphodiesterase-3 inhibitor milrinone attenuates pulmonary hypertension in a rat model of congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Favourable effect of statin therapy on early survival benefit at the time of percutaneous coronary intervention for ST-elevation myocardial infarction and shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Effect of statin therapy before Q-wave myocardial infarction on myocardial perfusion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Effect of statins on C-reactive protein in patients with coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Early statin treatment following acute myocardial infarction and 1-year survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Hypothermia; its possible role in cardiac surgery: an investigation of factors governing survival in dogs at low body temperatures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.194

Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?

31 March 2020

1 reference

12 December 2020

Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators

1 reference

12 December 2020

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the M

1 reference

12 December 2020

Thrombolysis and postinfarction ventricular septal rupture

1 reference

12 December 2020

Cardiac tamponade. A study of 50 hearts

1 reference

12 December 2020

Factors involved in salvaging ischemic myocardium: effect of reperfusion of arterial blood

1 reference

12 December 2020

The use of hypothermia after cardiac arrest

1 reference

12 December 2020

Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?

1 reference

12 December 2020

10.1038/NRCARDIO.2011.194

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22182955